- Home
- MOLN vs NMG Comparison
MOLN vs NMG Comparison
Compare MOLN & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- NMG
- Stock Information
- Founded
- MOLN 2004
- NMG 2011
- Country
- MOLN Switzerland
- NMG Canada
- Employees
- MOLN N/A
- NMG N/A
- Industry
- MOLN
- NMG Other Metals and Minerals
- Sector
- MOLN
- NMG Basic Materials
- Exchange
- MOLN Nasdaq
- NMG Nasdaq
- Market Cap
- MOLN 138.6M
- NMG 249.7M
- IPO Year
- MOLN 2021
- NMG 2017
- Fundamental
- Price
- MOLN $3.59
- NMG $1.85
- Analyst Decision
- MOLN
- NMG Strong Buy
- Analyst Count
- MOLN 0
- NMG 2
- Target Price
- MOLN N/A
- NMG $2.58
- AVG Volume (30 Days)
- MOLN 1.9K
- NMG 44.5K
- Earning Date
- MOLN 08-25-2025
- NMG 08-13-2025
- Dividend Yield
- MOLN N/A
- NMG N/A
- EPS Growth
- MOLN N/A
- NMG N/A
- EPS
- MOLN N/A
- NMG N/A
- Revenue
- MOLN $2,525,030.00
- NMG N/A
- Revenue This Year
- MOLN N/A
- NMG N/A
- Revenue Next Year
- MOLN $866.67
- NMG N/A
- P/E Ratio
- MOLN N/A
- NMG N/A
- Revenue Growth
- MOLN N/A
- NMG N/A
- 52 Week Low
- MOLN $3.36
- NMG $1.22
- 52 Week High
- MOLN $12.22
- NMG $2.58
- Technical
- Relative Strength Index (RSI)
- MOLN 43.66
- NMG 65.36
- Support Level
- MOLN $3.71
- NMG $1.64
- Resistance Level
- MOLN $3.89
- NMG $1.67
- Average True Range (ATR)
- MOLN 0.10
- NMG 0.05
- MACD
- MOLN -0.01
- NMG 0.02
- Stochastic Oscillator
- MOLN 20.00
- NMG 92.22
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.